Ladone Mary Kay

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ladone Mary Kay's trades of Kestra Medical Technologies Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
257.45
Quantity 19,475 +33.6%
Value US$2,987,394
Transaction date
Planned sale
Price
155.08
Quantity 2,051 -100.0%
Value US$318,069
Transaction date
Planned sale
Price
110.00
Quantity 2,278 -21.8%
Value US$250,580
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-10 2026-09-08
S Sale
10,028 -41.2%
135.39
US$66,316 		10,028 -41.2% 135.39 US$66,316
2026-09-08 2026-09-08
PrS Proposed sale
86,637
166.80
US$4,431,965 		86,637 166.80 US$4,431,965
2021-11-12 2021-11-11
PlS Planned sale
19,475 +33.6%
257.45
US$2,987,394 		19,475 +33.6% 257.45 US$2,987,394
2021-11-10 2021-11-08
PlS Planned sale
2,051 -100.0%
155.08
US$318,069 		2,051 -100.0% 155.08 US$318,069
2021-11-10 2021-11-08
PlS Planned sale
872 -100.0%
155.08
US$135,230 		872 -100.0% 155.08 US$135,230
2020-07-02 2020-06-30
PlS Planned sale
2,278 -21.8%
110.00
US$250,580 		2,278 -21.8% 110.00 US$250,580